OliX Pharmaceuticals announces positive results of phase 1 study of safety and tolerability of OLX10212

Press/Media

Period	2023.12.12

Media coverage

Title	OliX Pharmaceuticals announces positive results of phase 1 study of safety and tolerability of OLX10212
Media name/outlet	Modern Retina
Country/Territory	United States
Date	23.12.12
URL	https://www.modernretina.com/view/olix-pharmaceuticals-announces-positive-results-of-phase-1-study-of-safety-and-tolerability-of-olx10212
Persons	Kichang Lee